Peter Michael Moyle

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	2759	1532
h-endeksi	31	20
i10-endeksi	47	35

340

170

255

200720082009201020112012201320142015201620172018201920202021202220232024202519 48 58 35 72 68 85 90 110 142 152 140 193 254 302 324 282 324 46

Genel erişim

Tümünü görüntüle

16 makale

13 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Istvan TothChair in Biological Chemistryuq.edu.au üzerinde doğrulanmış e-posta adresine sahip
Michael F GoodGriffith Universitygriffith.edu.au üzerinde doğrulanmış e-posta adresine sahip
Mark WalkerThe University of Queenslanduq.edu.au üzerinde doğrulanmış e-posta adresine sahip
guido silvestriemory universityemory.edu üzerinde doğrulanmış e-posta adresine sahip
Ross McGearyThe University of Quenslanduq.edu.au üzerinde doğrulanmış e-posta adresine sahip
Dr. Anjuman Ara BegumResearcher, The University of Queenslanduq.edu.au üzerinde doğrulanmış e-posta adresine sahip
Mariusz SkwarczynskiUniversity of Queenslanduq.edu.au üzerinde doğrulanmış e-posta adresine sahip
Yu WanSouthwest Jiaotong Universityswjtu.edu.cn üzerinde doğrulanmış e-posta adresine sahip
Victor NizetDistinguished Professor of Pediatrics and Pharmacyucsd.edu üzerinde doğrulanmış e-posta adresine sahip
Seyed Ebrahim AlaviGriffith Universitygriffithuni.edu.au üzerinde doğrulanmış e-posta adresine sahip
Mehfuz ZamanResearch fellow. Institute for Glycomics, Griffith University, Gold Coast, QLDgriffith.edu.au üzerinde doğrulanmış e-posta adresine sahip
Dr James R. Falconer, PhDThe University of Queenslanduq.edu.au üzerinde doğrulanmış e-posta adresine sahip
Anna HenninghamUniversity of Queenslanduq.edu.au üzerinde doğrulanmış e-posta adresine sahip
Ashwini Kumar GiddamThe University of Queenslanduqconnect.edu.au üzerinde doğrulanmış e-posta adresine sahip
Associate Professor James W WellsGroup Leader, University of Queenslanduq.edu.au üzerinde doğrulanmış e-posta adresine sahip
Tom W. MuirPrinceton Universityprinceton.edu üzerinde doğrulanmış e-posta adresine sahip
Zhongfan JiaAssociate Professor, Flinders University, Australiaflinders.edu.au üzerinde doğrulanmış e-posta adresine sahip
Michael MonteiroProfessor of Polymer Chemistry, The University of Queenslanduq.edu.au üzerinde doğrulanmış e-posta adresine sahip
Andreas SuhrbierQIMR Berghoferqimrberghofer.edu.au üzerinde doğrulanmış e-posta adresine sahip

Takip et

Peter Michael Moyle

The University of Queensland

uq.edu.au üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

Proteins Peptides Vaccines Group A Streptococcus Gene Therapy


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Modern subunit vaccines: development, components, and research opportunities PM Moyle, I Toth ChemMedChem 8 (3), 360-376, 2013	524	2013
Self-adjuvanting lipopeptide vaccines PM Moyle, I Toth Current medicinal chemistry 15 (5), 506-516, 2008	193	2008
Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines PM Moyle Biotechnology advances 35 (3), 375-389, 2017	107	2017
Mucosal immunisation: adjuvants and delivery systems PM Moyle, RP McGeary, JT Blanchfield, I Toth Current Drug Delivery 1 (4), 385-396, 2004	102	2004
Glucagon‐like peptide‐1 (GLP‐1)‐based therapeutics: current status and future opportunities beyond type 2 diabetes JY Cheang, PM Moyle ChemMedChem 13 (7), 662-671, 2018	97	2018
Soil bacterial diffusible and volatile organic compounds inhibit Phytophthora capsici and promote plant growth SF Syed-Ab-Rahman, LC Carvalhais, ET Chua, FY Chung, PM Moyle, ... Science of the Total Environment 692, 267-280, 2019	89	2019
Method for the synthesis of mono-ADP-ribose conjugated peptides PM Moyle, TW Muir Journal of the American Chemical Society 132 (45), 15878-15880, 2010	78	2010
Glucagon-like peptide-1 receptor agonists and strategies to improve their efficiency SE Alavi, PJ Cabot, PM Moyle Molecular Pharmaceutics 16 (6), 2278-2295, 2019	75	2019
Structure–activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates ABM Abdel-Aal, MR Batzloff, Y Fujita, N Barozzi, A Faria, P Simerska, ... Journal of medicinal chemistry 51 (1), 167-172, 2008	72	2008
An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model T Rivera-Hernandez, DG Carnathan, S Jones, AJ Cork, MR Davies, ... MBio 10 (2), 10.1128/mbio. 00693-19, 2019	68*	2019
Modern lipid‐, carbohydrate‐, and peptide‐based delivery systems for peptide, vaccine, and gene products P Simerska, PM Moyle, I Toth Medicinal research reviews 31 (4), 520-547, 2011	64	2011
Polymer–peptide hybrids as a highly immunogenic single-dose nanovaccine AAH Ahmad Fuaad, Z Jia, M Zaman, J Hartas, ZM Ziora, IC Lin, PM Moyle, ... Nanomedicine 9 (1), 35-43, 2014	58	2014
Differing efficacies of lead group A streptococcal vaccine candidates and full-length M protein in cutaneous and invasive disease models T Rivera-Hernandez, M Pandey, A Henningham, J Cole, B Choudhury, ... MBio 7 (3), 10.1128/mbio. 00618-16, 2016	57	2016
Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccines PM Moyle, W Dai, Y Zhang, MR Batzloff, MF Good, I Toth Bioconjugate chemistry 25 (5), 965-978, 2014	57	2014
Bioconjugation approaches to producing subunit vaccines composed of protein or peptide antigens and covalently attached toll-like receptor ligands Z Xu, PM Moyle Bioconjugate chemistry 29 (3), 572-586, 2017	56	2017
Sortase A (SrtA) inhibitors as an alternative treatment for superbug infections S Alharthi, SE Alavi, PM Moyle, ZM Ziora Drug Discovery Today 26 (9), 2164-2172, 2021	55	2021
Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines PM Moyle, C Olive, MF Ho, M Pandey, J Dyer, A Suhrbier, Y Fujita, I Toth Journal of medicinal chemistry 50 (19), 4721-4727, 2007	53	2007
Oral vaccine delivery-new strategies and technologies P Simerska, PM Moyle, C Olive, I Toth Current Drug Delivery 6 (4), 347-358, 2009	51	2009
Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity M Zaman, S Chandrudu, AK Giddam, J Reiman, M Skwarczynski, ... Nanomedicine 9 (17), 2613-2624, 2014	49	2014
The contribution of non-human primate models to the development of human vaccines T Rivera-Hernandez, DG Carnathan, PM Moyle, I Toth, NP West, ... Discovery medicine 18 (101), 313, 2014	48	2014

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar